Stage I Marginal Zone Lymphoma Completed Phase 0 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0029479 (Stage I Marginal Zone Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00017381Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaTreatment